Consolidated Portfolio Review Corp Boston Scientific Corp Transaction History
Consolidated Portfolio Review Corp
- $723 Billion
- Q2 2025
A detailed history of Consolidated Portfolio Review Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Consolidated Portfolio Review Corp holds 3,136 shares of BSX stock, worth $332,855. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,136Holding current value
$332,855% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BSX
# of Institutions
1,861Shares Held
1.22BCall Options Held
9.67MPut Options Held
6.98M-
Vanguard Group Inc Valley Forge, PA135MShares$14.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.84 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.87 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.52 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $152B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...